Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
Pyridoxine and Cyanocobalamin and Folic Acid
Overview
What is Folbic?
Each rose colored tablet contains the following active ingredients: Folacin (Folic Acid) 2.5 mg, Pyridoxine (B6) 25mg, Cyanocobalamin (B12) 2mg, Folbic Tablets do not contain sugar or lactose.
Inactive Ingredients: Carmine, Croscarmellose Sodium, Dicalcium Phosphate, Hypromellose, Magnesium Silicate, Magnesium Stearate, Microcrystalline Cellulose, Mineral Oil, Riboflavin, Sodium Lauryl Sulfate, Stearic Acid, Titanium Dioxide and Triacetin.
What does Folbic look like?
What are the available doses of Folbic?
Sorry No records found.
What should I talk to my health care provider before I take Folbic?
Sorry No records found
How should I use Folbic?
Folbic Tablets are indicated for the distrinct nutritional requirements of individuals under a physician's supervision for hyperhomocysteinemia; with particular emphasis for individuals with or at risk for atheroscierotic vascular disease in the coronary, peripheral, or cerebral vessels, or vitamin B12 dificiency.
Usual adult dose is one to two tablets daily or as directed by a physician.
What interacts with Folbic?
Known hypersensitivity to any of the components in the product is a contraindication.
What are the warnings of Folbic?
If CDAD is suspected or confirmed, ongoing antibiotic use not directed
against may need to be discontinued.
Appropriate fluid and electrolyte management, protein supplementation,
antibiotic treatment of , and surgical
evaluation should be instituted as clinically indicated.
KEEP THIS AND ALL MEDICATIO OUT OF THE REACH OF CHILDREN IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.
All prescription substitutions using this product ahall be pursuant ot state statutes as applicable. This is not an Orange Book Product.
What are the precautions of Folbic?
General
Folacin (folic acid) when administered as a single agent in doses above 0.1 mg daily may obscure pemicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. The 2mgs of cyanocobalamin contained in Folbic Tablets has been shown to provide an adequate amount of cyanocobalamin to address this precaution. Unmetabolized folic acid has been shown in one study of 105 postmenopausal women (50-75 yrs) to have the potential to reduce natural killer cells' cytotoxicity, which may result in an impaired immune response.
Cyanocobalamin should not be used in those with Leber's optic atrophy. Decreased levels of B12 have been associated with reduced ability to detoxify the cyanide in exposed individuals and cyanocobalamin may increase the risk of irreversible neurological damage from optic atrophy in those affected with the disorder. Hydroxocobalamin can aid in the detoxification of cyanide. This form of B12 is an acceptable form for B12 supplementation in those with this disorder.
Drug Interactions
Pyridoxine supplements should not be given to patients receiving the drug levodopa, because the action of levodopa is antagonized by pyridoxine. However, pyridoxine may be used concurrently in patients recieving a a preparation containing both carbidopa and levodopa. Concurrent use of phenytoin and folacin (folic acid) may result in decreased phenytoin effectiveness.
Pregnancy
Pregnant women and nursing mothers should only use 12 microgram doses of B12 (cyanocobalamin) from nutritional supplements. Doses higher than this should only be recommended by your physician. Administration of doses of vitamin B12 greater than 10 micrograms daily may produce a hematological response in those with anemia secondary to folate deficiency.
If pregnant, or planning to become pregnant or are currently breast-feeding please contact your physician, or health-care provider before using or continuing use.
What are the side effects of Folbic?
Allergic sensitization has been reported following both oral an dparental administration of folacin (folic acid). Paresthesia, somnolence, nausea and headaches have been reported with pyridoxine. Mild transient diarrhea, polycythemis vera, itching, transitory exanthema, and the feeling of swelling of the entire body has been associated with cyanocobalamin.
What should I look out for while using Folbic?
Known hypersensitivity to any of the components in the product is a contraindication.
KEEP THIS AND ALL MEDICATIO OUT OF THE REACH OF CHILDREN IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.
All prescription substitutions using this product ahall be pursuant ot state statutes as applicable. This is not an Orange Book Product.
What might happen if I take too much Folbic?
Sorry No Records found
How should I store and handle Folbic?
Store at 25°C (77°F); excursions permitted between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature].Folbic Tablets are available as an oval, rose colored tablet, debossed B 384. Supplied in blisterpacks of 30 tablets, NDC# 0615-7575-39.Store at 25 degrees C (77 degrees F); excursions permitted to 15 degrees - 30 degrees C (59 degrees - 86 degrees F). See USP Controlled Room Temperature. Protect from light and moisture.Dispense in a tight, light resistant container with a child-resistant closure as defined in the USP/NF.Folbic Tablets are available as an oval, rose colored tablet, debossed B 384. Supplied in blisterpacks of 30 tablets, NDC# 0615-7575-39.Store at 25 degrees C (77 degrees F); excursions permitted to 15 degrees - 30 degrees C (59 degrees - 86 degrees F). See USP Controlled Room Temperature. Protect from light and moisture.Dispense in a tight, light resistant container with a child-resistant closure as defined in the USP/NF.Folbic Tablets are available as an oval, rose colored tablet, debossed B 384. Supplied in blisterpacks of 30 tablets, NDC# 0615-7575-39.Store at 25 degrees C (77 degrees F); excursions permitted to 15 degrees - 30 degrees C (59 degrees - 86 degrees F). See USP Controlled Room Temperature. Protect from light and moisture.Dispense in a tight, light resistant container with a child-resistant closure as defined in the USP/NF.
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
Non-Clinical Toxicology
Known hypersensitivity to any of the components in the product is a contraindication.KEEP THIS AND ALL MEDICATIO OUT OF THE REACH OF CHILDREN IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.
All prescription substitutions using this product ahall be pursuant ot state statutes as applicable. This is not an Orange Book Product.
Pyridoxine supplements should not be given to patients receiving the drug levodopa, because the action of levodopa is antagonized by pyridoxine. However, pyridoxine may be used concurrently in patients recieving a a preparation containing both carbidopa and levodopa. Concurrent use of phenytoin and folacin (folic acid) may result in decreased phenytoin effectiveness.
Folacin (folic acid) when administered as a single agent in doses above 0.1 mg daily may obscure pemicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. The 2mgs of cyanocobalamin contained in Folbic Tablets has been shown to provide an adequate amount of cyanocobalamin to address this precaution. Unmetabolized folic acid has been shown in one study of 105 postmenopausal women (50-75 yrs) to have the potential to reduce natural killer cells' cytotoxicity, which may result in an impaired immune response.
Cyanocobalamin should not be used in those with Leber's optic atrophy. Decreased levels of B12 have been associated with reduced ability to detoxify the cyanide in exposed individuals and cyanocobalamin may increase the risk of irreversible neurological damage from optic atrophy in those affected with the disorder. Hydroxocobalamin can aid in the detoxification of cyanide. This form of B12 is an acceptable form for B12 supplementation in those with this disorder.
Allergic sensitization has been reported following both oral an dparental administration of folacin (folic acid). Paresthesia, somnolence, nausea and headaches have been reported with pyridoxine. Mild transient diarrhea, polycythemis vera, itching, transitory exanthema, and the feeling of swelling of the entire body has been associated with cyanocobalamin.
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).